Super Formula for Soluble C-Type Lectin-Like Receptor 2 × D-Dimer in Patients With Acute Cerebral Infarction
Autor: | Toshitaka Kamon MD, Hideo Wada MD, PhD, Shotaro Horie MD, Tomoya Inaba MD, Karin Okamoto MD, Katsuya Shiraki MD, PhD, Yuhuko Ichikawa, Minoru Ezaki, Motomu Shimaoka MD, PhD, Akisato Nishigaki MD, Akihiro Shindo MD, PhD, Hideto Shimpo MD, PhD, Nobuo Ito MD |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024) |
Druh dokumentu: | article |
ISSN: | 1938-2723 10760296 |
DOI: | 10.1177/10760296241232858 |
Popis: | Acute cerebral infarction (ACI) includes atherosclerotic and cardiogenic ACI and involves a thrombotic state, requiring antithrombotic treatment. However, the thrombotic state in ACI cannot be evaluated using routine hemostatic examinations. Plasma soluble C-type lectin-like receptor 2 (sCLEC-2) and D-dimer levels were measured in patients with ACI. Plasma sCLEC-2 and D-dimer levels were significantly higher in patients with ACI than in those without it. The sCLEC-2 × D-dimer formula was significantly higher in patients with ACI than in those without it. A receiver operating characteristic curve showed a high sensitivity, area under the curve, and odds for diagnosing ACI in the sCLEC-2 × D-dimer formula. Although the sCLEC-2 and D-dimer levels were useful for the differential diagnosis between cardiogenic and atherosclerotic ACI, the sCLEC-2 × D-dimer formula was not useful. sCLEC2 and D-dimer levels are useful for the diagnosis of ACI and the sCLEC2 × D-dimer formula can enhance the diagnostic ability of ACI, and sCLEC2 and D-dimer levels may be useful for differentiating between atherosclerotic and cardioembolic ACI. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |